efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BRASIL. Ministério <strong>da</strong> Saúde. Consenso Brasileiro em Doença de Chagas. Diagnóstico e<br />
manejo clínico <strong>da</strong> forma cardíaca <strong>da</strong> <strong>do</strong>ença de Chagas. Rev Soc Bras Med Trop,<br />
Brasília, v.38(supl.3): p.15-18, 2005.<br />
BRAUNWALD, E. Congestive heart failure: a half century perspective. European Heart<br />
Journal, Lon<strong>do</strong>n, v.22: p.825-836, 2001.<br />
CHAGAS, C. Nova tripanosomíase humana. Mem Inst Oswal<strong>do</strong> Cruz. Rio de Janeiro,<br />
v.1: p.15 90218, 1909.<br />
CHAGAS, C.; VILLELA, E. Forma cardíaca <strong>da</strong> trypanosomíase americana. Mem Inst<br />
Oswal<strong>do</strong> Cruz, Rio de Janeiro, v.14: p.5-61, 1922.<br />
CHIALE, P.A. et al. High prevalence of antibodies against beta 1- and beta 2adrenoceptors<br />
in patients with primary electrical cardiac abnormalities. J Am Coll<br />
Cardiol, New York, v.26: p.864-9, 1995.<br />
CHIALE, P.A. et al. Differential profile and biochemical effects of antiautonomic<br />
membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction.<br />
Circulation, Dallas, v.3;n.103(13): p.1765-71, Apr 2001.<br />
CHIZNER, M.A. The diagnosis of heart disease by clinical assessment alone. Dis Mon,<br />
[s.l.], v.48: p.1-100, 2002.<br />
CIBIS. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a ran<strong>do</strong>mised trial.<br />
CIBIS-II Investigators and committee. Lancet, Lon<strong>do</strong>n, v.353;n.9146: p.9-13, 1999.<br />
COCA, S.G.; PERAZELLA, M.A. The role of al<strong>do</strong>sterone blockers in the management of<br />
chronic heart failure. Am J Med Sci, New York, v.330;n.4: p.176-83, 2005.<br />
COCKCROFT, D.W.; GAULT, M.H. Prediction of creatinine clearance from serum<br />
creatinine. Nephron, Berlin, v.16,n.1: p.31-41, 1976.<br />
COHN, J.N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic<br />
congestive heart failure. N Engl J Méd, Boston, v.311: p.819, 1984.<br />
COHN, J.N. et al. Effect of Vasodilatator Therapy on mortality in cronic congestive heart<br />
failure. N Eng J Med, Boston, v.314: p.1547-52, 1986.<br />
COHN, J.N. The sympathetic nervous system in heart failure. J Cardiovasc Pharmacol,<br />
[s.l.], v.14;n.57, 1989.<br />
COHN, J.N.; JOHNSON, G. Heart failure with normal ejection fraction. The V-HeFT<br />
Study. Veterans Administration Cooperative Study Group (VHeFT2). Circulation, Dallas,<br />
81(2 Suppl): III48-53, Feb. 1990.<br />
COLUCCI, W.S. et al. Calcium channel blockers in congestive heart failure: theoretic<br />
considerations and clinical experience. Am J Of Med, Newton, v.78: p.9-17, 1985.<br />
129
Change language